Feb 28,2022

Impact of Blood Glucose Monitoring System Accuracy on Clinical Decision Making for Diabetes Management

This article provides health care professionals and users with an intuitive illustration of the impact of BGMS accuracy on clinical decision making.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Feb 28,2022

Role of Telemedicine in Diabetes Management

This review explores the landscape of telemedicine approaches and evidence for incorporation into general practice.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Feb 28,2022

Evaluation of a New Clinical Tool to Enhance Clinical Care of Control-IQ Users

The purpose of this study was to develop and test a new Clinic Tool to assist health care professionals with clinical care of persons with diabetes using the Control-IQ system.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Feb 28,2022

Better Therapeutics Announces New CMS HCPCS Code for Prescription Digital Behavioral Therapies (PDTs)

Better Therapeutics, Inc. (“Better Therapeutics”, NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, announces a new code from the Center for Medicare and Medicaid Services (CMS) that paves the way for reimbursement of these therapies.

View Analyst & Ambassador Comments
Go to original news
Feb 28,2022

Nemaura Medical Wins Innovation Awards

Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces it received the top award as Innovator of the Year at the LeicestershireLive Innovation Awards 2022 held on February 24, 2022.

View Analyst & Ambassador Comments
Go to original news
Feb 28,2022

Brighter reports its year-end report 2021

Brighter AB, today reported its year-end report 2021.

View Analyst & Ambassador Comments
Go to original news
Mar 01,2022

Military Members, Families and Retirees Get Simplified Access to Abbott’s FreeStyle® Libre 2 system Through TRICARE®

Abbott announced today that its FreeStyle® Libre 2 flash glucose monitoring system (CGM) is now available as a brand-name formulary pharmacy benefit to military members, their families and retirees with TRICARE® health coverage. This will make it easier for TRICARE members to access industry-leading monitoring technology1 to manage their diabetes.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 01,2022

ASCENSIA DIABETES CARE LAUNCHES THE EVERSENSE NOW REMOTE MONITORING APP FOR ANDROID USERS IN EUROPE

Ascensia Diabetes Care, a global diabetes care company, announces that it has launched the Eversense® NOW Remote Monitoring App for the Android Operating System in Europe. With this launch, remote monitoring capabilities are now available for all Eversense® and Eversense® XL Continuous Glucose Monitoring (CGM) users on Android and iOS operating systems in the US and Europe, respectively.

PRODUCT

#mobile app

#cgm

View Analyst & Ambassador Comments
Go to original news
Mar 01,2022

BD Names William 'Bill' Brown to Board of Directors

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of William "Bill" Brown to its board of directors, effective Feb. 28, 2022.

View Analyst & Ambassador Comments
Go to original news
Mar 01,2022

FreeStyle Libre Flash Glucose Monitoring system for people with type 1 diabetes in the UK: a budget impact analysis

This study aims to estimate the budget impact of increased uptake of the FreeStyle Libre Flash Glucose Monitoring system in people with type 1 diabetes mellitus (T1DM) in the UK.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES